NO20063233L - Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning - Google Patents

Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning

Info

Publication number
NO20063233L
NO20063233L NO20063233A NO20063233A NO20063233L NO 20063233 L NO20063233 L NO 20063233L NO 20063233 A NO20063233 A NO 20063233A NO 20063233 A NO20063233 A NO 20063233A NO 20063233 L NO20063233 L NO 20063233L
Authority
NO
Norway
Prior art keywords
long
dosage
procedure
induced
release opioid
Prior art date
Application number
NO20063233A
Other languages
English (en)
Norwegian (no)
Inventor
Nipun Davar
Gayatri Sathyan
Linda H Pors
Gemma Casadevall
Jayne Hastedt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20063233L publication Critical patent/NO20063233L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20063233A 2005-10-31 2006-07-11 Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning NO20063233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73199505P 2005-10-31 2005-10-31
US80201706P 2006-05-18 2006-05-18

Publications (1)

Publication Number Publication Date
NO20063233L true NO20063233L (no) 2007-05-02

Family

ID=36758362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063233A NO20063233L (no) 2005-10-31 2006-07-11 Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning

Country Status (11)

Country Link
BG (1) BG1070U1 (sv)
CA (6) CA2554684A1 (sv)
CZ (1) CZ19137U1 (sv)
DK (1) DK200600189U3 (sv)
FI (1) FI7357U1 (sv)
GB (1) GB0612326D0 (sv)
IE (1) IES20060507A2 (sv)
NL (1) NL1032148C1 (sv)
NO (1) NO20063233L (sv)
SE (1) SE0601589L (sv)
SK (1) SK5202Y1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2692437T3 (es) 2007-08-13 2018-12-03 Abuse Deterrent Pharmaceutical Llc Fármacos resistentes al abuso, método de uso y método de preparación
US20140275149A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
US10172842B2 (en) * 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine

Also Published As

Publication number Publication date
GB0612326D0 (en) 2006-08-02
CA2554874A1 (en) 2007-04-30
CZ19137U1 (cs) 2008-12-08
CA2554693A1 (en) 2007-04-30
DK200600189U3 (da) 2007-02-23
FI7357U1 (sv) 2007-01-16
SK5202Y1 (en) 2009-06-05
BG1070U1 (bg) 2008-06-30
SK50572006U1 (en) 2009-01-07
IES20060507A2 (en) 2007-05-30
FIU20060296U0 (sv) 2006-07-12
CA2554684A1 (en) 2007-04-30
CA2554697A1 (en) 2007-04-30
CA2554701A1 (en) 2007-04-30
SE0601589L (sv) 2007-05-01
NL1032148C1 (nl) 2006-11-17
CA2554698A1 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
NO20064997L (no) Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
BRPI0806527A2 (pt) Uso de dtx e drx em um sistema de comunicação sem fio.
WO2009117482A8 (en) Mtor inhibitor salt forms
MX2009007254A (es) Composiciones de tableta en tableta.
CL2011001331A1 (es) Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo.
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
IT1392903B1 (it) Composizione comprendente un'associazione di principi attivi per uso nel trattamento topico della calvizie
MX2022001251A (es) Composiciones y metodos para reducir eventos adversos cardiovasculares graves.
MX359639B (es) Metodos y composiciones para uso en tratamientos celulares.
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
NZ589517A (en) A pharmaceutical composition comprising rebamipide
MY161601A (en) Films and compositions comprising the same
EA200900634A1 (ru) Применение блок-сополимеров на основе виниллактамов и винилацетата в качестве солюбилизаторов
NO20063233L (no) Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning
NO20072890L (no) Behandling av mastitt
UA105827C2 (uk) Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор
CL2007003198A1 (es) Compuestos diarilicos opcionalmente nitrogenados, antagonistas de los receptores opioides; composicion farmaceutica; y uso en el tratamiento de la obesidad.
FR2918460B1 (fr) Nouveau dispositif permettant l'obtention des resultats des systemes abo,rhesus et autres pherotypes et systemes rares, rai.
UA108993C2 (en) MEDICINAL COMBINATION WITH THEOBROMINE AND ITS APPLICATION IN Cough
ATE510594T1 (de) Hustenpräparat
CO6551745A2 (es) Combinación de fármacos con teobromina y su uso en terapia
EP1849460A3 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
MX2009005640A (es) Metodos para el tratamiento del abuso, adiccion y dependencia del alcohol.
TR201803744T4 (tr) Skleroderma tedavisinde kullanım için naltrekson içeren bileşimler.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application